A closer look at the technologies used by Verseau Therapeutics
Verseau Therapeutics
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
47 Wiggins Ave, Bedford, Massachusetts, ...Phone Number
(781) 285-6400Website
www.verseautx.comRevenue
$15.9 MillionIndustry
About Verseau Therapeutics
Verseau Therapeutics is focused on developing innovative cancer immunotherapies that promote the transformation of immuno-suppressive M2 macrophages into pro-inflammatory M1 macrophages. Their proprietary discovery engine has identified over 20 targets for regulating macrophage biology, which are crucial for enhancing immune responses against cancer. The company is advancing two lead programs targeting PSGL-1 and VSIG4 towards clinical application. Their intended clients include cancer patients and healthcare providers seeking advanced treatment options.Explore more
SIC Code 28,283NAICS Code 32,325Show moreCompare Similar Companies to Verseau Therapeutics
Compare insights from companies similar to Verseau Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Verseau Therapeutics
$15.9M
11-50
Private
-
2017
N/A
Verseau Therapeutics Tech Stack
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Verseau Therapeutics
Sign Up For FreeTo access detailed company insights
Verseau Therapeutics is focused on developing innovative cancer immunotherapies that promote the transformation of immuno-suppressive M2 macrophages into pro-inflammatory M1 macrophages. Their proprietary discovery engine has identified over 20 targets for regulating macrophage biology, which are crucial for enhancing immune responses against cance... Read More